Publications by authors named "D P Modest"

Claim this Profile
I
Individual Patient Data Meta-Analysis of Consensus Molecular Subtypes as Biomarkers of First-Line Treatment in Wild-Type Metastatic Colorectal Cancer.
Arndt Stahler, Dominik Paul Modest, Sebastian Stintzing, Beatrice Borelli, Theresa Keller

J Clin Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to 'A temporal paradox in the proposed risk-adjusted surveillance algorithm for metastatic colorectal cancer'.
M M Germani, D P Modest

Ann Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group).
Lena Weiss, Sebastian Stintzing, Dominik Paul Modest, Arndt Stahler, Ludwig Fischer von Weikersthal

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer - A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial.
Kathrin Heinrich, Sebastian Stintzing, Ludwig Fischer von Weikersthal, Thomas Decker, Alexander Kiani, Dominik Paul Modest

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Radiochemotherapy and Total Neoadjuvant Therapy in the Management of Locally Advanced Rectal Cancer.
Mücahit Yigit, Siyer Roohani, Annika Kurreck, Robert Siegel, Dominik P Modest

Cureus· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis